Cargando…

Genome-wide association study identified six loci associated with adverse drug reactions to aripiprazole in schizophrenia patients

Aripiprazole is recommended for routine use in schizophrenia patients. However, the biological mechanism for the adverse drug reactions (ADRs) among schizophrenia patients with the antipsychotic drug aripiprazole is far from clear. To explore the potential genetic factors that may cause movement-rel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Xueping, Mei, Dongli, Lu, Zhe, Zhang, Yuyanan, Sun, Yaoyao, Lu, Tianlan, Yan, Hao, Yue, Weihua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10368716/ https://www.ncbi.nlm.nih.gov/pubmed/37491364 http://dx.doi.org/10.1038/s41537-023-00369-6

Ejemplares similares

Association of NKAPL rs1635 With Cognitive Function in Early-Onset Schizophrenia
por: Yang, Yang, et al.
Publicado: (2022)

ATAD3B and SKIL polymorphisms associated with antipsychotic-induced QTc interval change in patients with schizophrenia: a genome-wide association study
por: Lu, Zhe, et al.
Publicado: (2022)

Aripiprazole-associated tic in a schizophrenia patient
por: Guo, Xieli, et al.
Publicado: (2015)

Multigenetic Pharmacogenomics–Guided Treatment vs Treatment As Usual Among Hospitalized Men With Schizophrenia: A Randomized Clinical Trial
por: Kang, Zhewei, et al.
Publicado: (2023)

Aripiprazole for late-life schizophrenia
por: Rado, Jeffrey, et al.
Publicado: (2010)

Review of depot aripiprazole for schizophrenia
por: Motiwala, Farha Bilal, et al.
Publicado: (2013)

C677T Polymorphism in the MTHFR Gene Is Associated With Risperidone-Induced Weight Gain in Schizophrenia
por: Liao, Jingping, et al.
Publicado: (2020)

Dissecting the causal association between social or physical inactivity and depression: a bidirectional two-sample Mendelian Randomization study
por: Zhao, Guorui, et al.
Publicado: (2023)

Role of aripiprazole in treatment-resistant schizophrenia
por: Mossaheb, Nilufar, et al.
Publicado: (2012)

Growth arrest specific gene 7 is associated with schizophrenia and regulates neuronal migration and morphogenesis
por: Zhang, Zhengrong, et al.
Publicado: (2016)

Phosphodiesterase and psychiatric disorders: a two-sample Mendelian randomization study
por: Jiang, Miaomiao, et al.
Publicado: (2023)

Oxidative Stress and Psychiatric Disorders: Evidence from the Bidirectional Mendelian Randomization Study
por: Lu, Zhe, et al.
Publicado: (2022)

High-risk group and functional subtypes of non-suicidal self-injury in young adults with mental disorders
por: Yan, Huiru, et al.
Publicado: (2023)

Aripiprazole: the evidence of its therapeutic impact in schizophrenia
por: Winlow, William, et al.
Publicado: (2006)

Effect of Aripiprazole on Mismatch Negativity (MMN) in Schizophrenia
por: Zhou, Zhenhe, et al.
Publicado: (2013)

Replication of Association between Schizophrenia and Chromosome 6p21-6p22.1 Polymorphisms in Chinese Han Population
por: Zhang, Yang, et al.
Publicado: (2013)

Evidence for Association of Cell Adhesion Molecules Pathway and NLGN1 Polymorphisms with Schizophrenia in Chinese Han Population
por: Zhang, Zhengrong, et al.
Publicado: (2015)

Genetic Polymorphisms Associated With the Pharmacokinetics, Pharmacodynamics and Adverse Effects of Olanzapine, Aripiprazole and Risperidone
por: Soria-Chacartegui, Paula, et al.
Publicado: (2021)

Comparison of the probability of four anticonvulsant mood stabilizers to facilitate polycystic ovary syndrome in women with epilepsies or bipolar disorder—A systematic review and meta-analysis
por: Guo, Jing, et al.
Publicado: (2023)

Genome-wide Association Analysis Identifies 14 New Risk Loci for Schizophrenia
por: Ripke, Stephan, et al.
Publicado: (2013)

Genome wide association study identifies four loci for early onset schizophrenia
por: Guo, Suqin, et al.
Publicado: (2021)

Pharmacological treatment strategies for antipsychotic-induced hyperprolactinemia: a systematic review and network meta-analysis
por: Lu, Zhe, et al.
Publicado: (2022)

Peripheral non-enzymatic antioxidants as biomarkers for mood disorders: Evidence from a machine learning prediction model
por: Gong, Yuandong, et al.
Publicado: (2022)

A case-control association study of NRXN1 polymorphisms with schizophrenia in Chinese Han population
por: Yue, Weihua, et al.
Publicado: (2011)

Association of chromosome 5q21.3 polymorphisms with the exploratory eye movement dysfunction in schizophrenia
por: Ma, Yuanlin, et al.
Publicado: (2015)

Differences in autonomic nervous system activity between long-acting injectable aripiprazole and oral aripiprazole in schizophrenia
por: Hattori, Saki, et al.
Publicado: (2023)

Efficacy and tolerability of Aripiprazole in Patients with Schizophrenia & Schizoaffective Disorders
por: Andrade, Chittaranjan
Publicado: (2004)

Efficacy and Tolerability of Aripiprazole in Patients with Schizophrenia & Schizoaffective Disorders
por: Chavda, R.K., et al.
Publicado: (2004)

Retrospective Study of Japanese Patients with Schizophrenia Treated with Aripiprazole
por: Tanioka, Tetsuya, et al.
Publicado: (2012)

Treatment of refractory catatonic schizophrenia with low dose aripiprazole
por: Sasaki, Tsuyoshi, et al.
Publicado: (2012)

Dose-response analysis of aripiprazole in patients with schizophrenia in Taiwan
por: Tien, Yun, et al.
Publicado: (2022)

Evidence for association between Disrupted-in-schizophrenia 1 (DISC1) gene polymorphisms and autism in Chinese Han population: a family-based association study
por: Zheng, Fanfan, et al.
Publicado: (2011)

Meta-Analysis of Genome-Wide Association Studies Identifies Six New Loci for Serum Calcium Concentrations
por: O'Seaghdha, Conall M., et al.
Publicado: (2013)

Fluvoxamine for aripiprazole-associated akathisia in patients with schizophrenia: a potential role of sigma-1 receptors
por: Furuse, Tsutomu, et al.
Publicado: (2010)

Recurrent Episodes of Paraphilic Behavior Possibly Associated With Olanzapine and Aripiprazole Treatment in a Patient With Schizophrenia
por: Stefanou, Maria-Ioanna, et al.
Publicado: (2020)

Antipsychotic drug—aripiprazole against schizophrenia, its therapeutic and metabolic effects associated with gene polymorphisms
por: Stelmach, Adriana, et al.
Publicado: (2022)

Variants of GRM7 as risk factor and response to antipsychotic therapy in schizophrenia
por: Liang, Wei, et al.
Publicado: (2020)

Use of Aripiprazole Long Acting Injection in Negative Symptoms of Schizophrenia
por: James, Suneeta, et al.
Publicado: (2016)

Cost-Utility Analysis of Lurasidone Versus Aripiprazole in Adults with Schizophrenia
por: Rajagopalan, Krithika, et al.
Publicado: (2016)

A Case of Hypersexuality in a Patient Receiving Aripiprazole for Schizophrenia
por: Priya, Lakshmi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_c9elfb92ehtf0s3chvgr90f9d8